Publication | Open Access
Self-administered intranasal etripamil using a symptom-prompted, repeat-dose regimen for atrioventricular-nodal-dependent supraventricular tachycardia (RAPID): a multicentre, randomised trial
32
Citations
11
References
2023
Year
Milestone Pharmaceuticals.
| Year | Citations | |
|---|---|---|
Page 1
Page 1